2016 May 10
Women Who Use Their Bodies For Work
Surgeon Tracy-Ann Moo, M.D., is featured in a photo series about women at work. Read more
2016 May 09
Cantley becomes Hope Funds honoree
Lewis Cantley, Ph.D., is one of four recipients of a Hope Funds 2016 Award of Excellence. Read more
2016 May 08
Ovarian cancer survivor says her pregnancy 'saved' her life
Kevin Holcomb, M.D., discusses symptoms of ovarian cancer that are often ignored. Read more
2016 May 05
Cancer is a low-down, dirty gangster ninja
Harold Varmus, M.D., discusses the dynamic nature of cancer and why it is such a difficult series of diseases to treat. Read more
2016 May 05
Prostate cancer screening guidelines called into question
Jim Hu, M.D., has questioned the results of a large-scale clinical trial assessing the value of PSA screening that served as the basis for national screening guidelines. Read more
2016 May 04
Mason awarded Pershing Square Sohn Cancer Research prize
Christopher Mason, Ph.D., is one of seven researchers to receive the Young Investigators in Cancer Research prize. Read more
2016 May 02
MDx for Prostate Cancer
Mark Rubin, M.D., discusses the importance of biomarkers to distinguish indolent from aggressive cancer. Read more
2016 Apr 28
Advantages with Whole-Exome Sequencing
Mark A. Rubin, M.D., talks to OncLive about the advantages of whole-exome sequencing and how it compares with targeted sequencing. Read more
2016 Apr 28
At the crossroads in surgical education
Heather Yeo, MD, MHS, assistant professor of surgery and assistant professor of public health, wrote a guest post on the Association of Women Surgeons blog. Read the original here . Dr. Heather Yeo and her father. Over the... Read more
2016 Apr 27
7 Signs of Ovarian Cancer You Might Be Ignoring
Kevin Holcomb, M.D., discusses some of the "silent" symptoms of ovarian cancer. Read more
2016 Apr 26
What the gut? Two studies explore microbiome-cancer connection
Teams at Weill Cornell Medicine are exploring the complex workings of the gastrointestinal microbiota and metabolome. Read more
2016 Apr 25
Cranberry compound packs powerful cancer punch
A compound made from cranberries has shown promise in killing several leukemia cell lines and blood samples from acute myelogenous leukemia (AML) patients. Read more
2016 Apr 25
Teenager helps ID new target for aggressive leukemia
Michael Albert, 17, has worked with the lab of Monica Guzman, Ph.D., to identify ephrin receptors as potential therapeutic targets for acute myeloid leukemia. Read more
2016 Apr 25
Drug developed for lymphoma could provide hope for lung cancer patients
The lab of Leandro Cerchietti, M.D., has revealed early evidence that a BCL6 inhibitor initially studied as a potential B-cell lymphoma treatment might also be effective against chemo-resistant non-small cell lung cancers. Read more
2016 Apr 21
Questions on PD-L1 Diagnostics for Immunotherapy in NSCLC
Brendon Stiles, M.D., comments on the immunotherapies available to treat non-small cell lung cancer. Read more
2016 Apr 21
10 Things Cancer Experts Do To Avoid Getting The Disease
Allyson Ocean, M.D., shares some pointers with Prevention Magazine. Read more
2016 Apr 20
Copper depletion may reduce breast cancer relapse in patients at high risk
Linda Vahdat, M.D., shares results of studies into copper depletion as a potential therapy for triple-negative breast cancer. Read more
2016 Apr 19
Hollywood star honors star Meyer researchers
Weill Cornell Medicine researchers Juan Cubillos-Ruiz, Ph.D., and Dan Landau, M.D., Ph.D., were two of 10 young investigators nationwide who received Innovative Research Grants from Stand Up To Cancer. Read more
2016 Apr 19
Computer to clinic: Tool developed at Weill predicts drug success
A computational tool created by a graduate student in the lab of Olivier Elemento, Ph.D, has realized its first clinical application - less than a year after its development. Read more
2016 Apr 18
First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer
Scott Tagawa, M.D., M.S., discusses the results of a phase I/II trial into a promising new immunotherapy drug for bladder cancer. Read more
